
What Is GHK-Cu? Effects on Skin, Hair, and Healing
Published on August 7, 2026
What is GHK-Cu, and what can you expect? Effects on skin, hair, and healing, available studies, user experiences, and risks of serums and injections.

Published on August 7, 2026
What is GHK-Cu, and what can you expect? Effects on skin, hair, and healing, available studies, user experiences, and risks of serums and injections.

Published on August 3, 2026
The BPC-157 doses people use most often, how long a cycle typically lasts, where the peptide is injected, and how long its effects may persist.

Published on August 1, 2026
BPC-157 has a reputation as a miracle peptide and, together with TB-500, makes up the Wolverine stack. Why do people use it for tendons, and what do we actually know about its effects?

Published on July 29, 2026
Four weeks on retatrutide: how it affected my hunger, portion sizes, sweet cravings, and performance—and why I would approach it differently today.
Published on July 27, 2026
GLP-1 is a gut hormone. How does it affect insulin, glucagon, hunger, and the stomach — and what is a GLP-1 receptor agonist?

Published on July 22, 2026
Peptides are a vast group of molecules. Online, however, the term often refers to a handful of bioactive substances associated with weight loss, recovery, or hormones. What is the difference between them?

Published on July 10, 2026
Retatrutide trials target maximum weight loss in patients with obesity. A regular person in a diet phase often needs something different: moderate appetite control, lower doses, and fewer adverse effects. This is a harm-reduction analysis of split dosing, not medical advice.
Published on July 9, 2026
Biological half-life tells you how long it takes for the concentration of a substance in the blood to fall by half. It is central to understanding dosing — and it is always an approximation.
Published on July 9, 2026
The maximum concentration of a molecule in the blood after dosing. A clear explanation of Cmax, when it occurs, and why it matters for adverse effects.
Published on July 9, 2026
Retatrutide activates the GLP-1, GIP, and glucagon receptors. What have studies shown, why has it generated so much hype, and what do we still not know?

Published on July 9, 2026
Steady state is the point where regular dosing produces a stable blood level of a medicine. Why the semaglutide level after the first injection is exactly half of steady state, and what that means for titration.